Thomas Guiel
Chief Operating Officer at OXFORD BIODYNAMICS PLC
Net worth: 62 195 $ as of 30/05/2024
Profile
Thomas G.
Guiel is currently the Chief Operating Officer at Oxford BioDynamics Plc.
Previously, he held positions as Principal at Invitrogen Corp., Vice President-Operations at OpGen, Inc., and Chief Operating Officer & Executive Vice President at OncoPlex Diagnostics, Inc. from 2013 to 2018.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OXFORD BIODYNAMICS PLC
0.20% | 02/04/2024 | 623,888 ( 0.20% ) | 62 195 $ | 30/05/2024 |
Thomas Guiel active positions
| Companies | Position | Start |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Chief Operating Officer | - |
Former positions of Thomas Guiel
| Companies | Position | End |
|---|---|---|
OncoPlex Diagnostics, Inc.
 OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Chief Operating Officer | 31/12/2017 |
| OPGEN, INC. | Chief Operating Officer | - |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OPGEN, INC. | Commercial Services |
| OXFORD BIODYNAMICS PLC | Health Technology |
| Private companies | 2 |
|---|---|
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Health Services |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
- Stock Market
- Insiders
- Thomas Guiel
